Call us: 1.405.235.2305
info@i2E.org
  • Events
  • News
  • Resources
  • Library
  • Love’s Cup
i2Ei2Ei2Ei2E
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
  • e3
  • Concept Fund
  • iMCI
  • Portfolio
  • Contact

i2E leads $11.5 million investment in Oklahoma City-based Linear Health Sciences

    Home Featured i2E leads $11.5 million investment in Oklahoma City-based Linear Health Sciences
    NextPrevious

    i2E leads $11.5 million investment in Oklahoma City-based Linear Health Sciences

    By sarah | Featured, News | 0 comment | 1 April, 2020 | 0

    April 1, 2020

    Contact: Sarah Seagraves,
    Senior VP for Marketing
    (405) 813-2403
    sseagraves@i2E.org

    Oklahoma City, OK-based Linear Health Sciences has developed a globally patented medical device known as the Orchid Safety Release Valve (SRV), designed to limit disconnection of IV catheters for patients worldwide.

    OKLAHOMA CITY — i2E Management Company, Inc. (iMCI), recently led an $11.535 million go-to-market investment in Oklahoma City-based Linear Health Sciences. The investment comes on the heels of continued successes for the Orchid SRV, the company’s flagship medical device designed to reduce accidental IV catheter dislodgement in a novel way.

    The iMCI-led investment in Linear Health Sciences includes $2.5 million from Plains Venture Partners I, as well as $1,000,000 from the Accelerate Oklahoma Fund and $500,000 from the Oklahoma Angel Fund II. Plains Venture Partners I, the Accelerate Oklahoma Fund, and the Oklahoma Angel Fund are each managed by iMCI. The remainder of the round was completed by local investors.

    The $11.535 million Series B investment round follows a $1.25 million Seed round in 2016 and a $1.54 million Series A in 2018, both led by i2E, Inc., parent company of iMCI.

    Co-founded by Oklahoma physician Dr. Ryan Dennis, CEO, and Dan Clark, President, Linear Health Sciences is preparing to launch its globally patented device known as the Orchid Safety Release Valve (SRV), designed to reduce dislodgement of IV catheters from patients in most clinical settings. The company claims unwanted IV catheter dislodgement costs the U.S. Healthcare system over $1 billion annually, not to mention pain and treatment interruptions experienced by patients.

    “The concept of our device is quite simple,” Clark said. “If you’ve ever seen someone drive away from a gas station with the hose still in the car, the hose rips away from the terminal, but no gas is spewing from the terminal and no gas is coming out of the car.

    “We did the same thing, but we did it for your veins.”

    “This funding round cements our relationships with elite partners and slingshots us toward our ultimate goal of improving the standard of care for how patients everywhere are connected to their treatments,” Dr. Dennis said.

    Plains Venture Partners is a growth-oriented venture fund focused on investing in entrepreneurs and technologies with a strong potential for disruption. Plains evaluates companies that have established proof of concept, including strong market validation and a demonstrated ability to execute. Plains is committed to deploying capital across the central United States in teams that are capable, efficient and poised for growth.

    The Accelerate Oklahoma Fund was created in 2011 by i2E to invest in Oklahoma-based startups and is managed by iMCI.

    The Oklahoma Angel Fund is a pooled fund of individual angel investors, managed by iMCI, offering another source of potential investment for Oklahoma entrepreneurs.

    About Linear Health Sciences

    Founded by Ryan Dennis, M.D., and Dan Clark, Linear Health Sciences is a globally recognized MedTech Innovator company whose innovations address the issue of tension-based dislodgement of medical tubing for patients in most clinical settings. https://linearsciences.com/

    About i2E Management Co. Inc.

    i2E Management Company, Inc. (iMCI) is a private, for profit investment and fund management company operating as a wholly owned subsidiary of i2E, Inc. iMCI currently manages $81 million across five venture funds. iMCI makes investment decisions and provides investment management as General Partner and/or Managing Member of a growing number of privately managed venture capital funds. Since 2007, iMCI and i2E, Inc. have invested more than $50 million of equity funding into 62 companies. i2E.org

     

    Accelerate Oklahoma! Fund, Dan Clark, i2E Management Co. Inc., Linear Health Sciences, M.D., Oklahoma Angel Fund, Orchid Safety Release Valve, Plains Venture Partners, Ryan Dennis

    Related Posts

    • Linear Health Sciences founder ‘living his dream’

      By sarah | 0 comment

      By Scott Meacham Copyright © 2019, The Oklahoman During one of the earliest conversations I had with Dr. Ryan Dennis, CEO of Linear Health Sciences, he told me that he was living his dream. IRead more

    • Linear Health Sciences’ selection for accelerator program demonstrates Oklahoma success

      By sarah | 0 comment

      By Scott Meacham Copyright © 2017, The Oklahoma Publishing Co. It’s pretty impressive when an Oklahoma startup, in this case, Linear Health Sciences, is hand-picked to be the first company to qualify for a newRead more

    • Linear Health Sciences Receives Grant to Work with Global Center for Medical Innovation

      By sarah | 0 comment

      Contact: Liz Dowling Dowling & Dennis Public Relations Tel. 415-388-2794 Liz@dowlingdennis.net Company Is First to Qualify for GCMI Medtech Accelerator Program OKLAHOMA CITY, Oklahoma – Linear Health Sciences, developer of the Orchid™ Safety Release ValveRead more

    • i2E invests in medical innovation

      By admin | Comments are Closed

      i2E Inc. recently led a $1.25 million seed round investment in Linear Health Sciences, a Norman-based innovative medical technology startup.

    • Telemedicine poised for growth because of pandemic, says Linear Health Sciences co-founder

      By sarah | Comments are Closed

      By Scott Meacham This second column in our series with Oklahoma thought leaders discussing the short- and long-term effects of the COVID pandemic is a from-the-trenches view of the pandemic’s impact on the medical industry.Read more

    Leave a Comment

    Cancel reply

    Your email address will not be published. Required fields are marked *

    NextPrevious
    i2E-300dpi-Trans-Light
    • Events
    • News
    • Resources
    • Library
    • Love’s Cup

    Oklahoma City Office

    840 Research Parkway, Suite 250
    OKC, OK 73104
    PHONE 405/235-2305
    Click HERE for printable map with directions.

    Tulsa Office

    618 E. Third Street, Suite 1
    Tulsa, OK 74120
    PHONE 918/582-5592
    Click HERE for printable map with directions.
    Copyright 2021 i2E, Inc. | All Rights Reserved
    • About i2E
    • Services
    • Investments
    • Development
      • Love’s Cup
        • Forms
        • High Growth
        • Small Business
        • Timeline
    • Portfolio 3
    • Contact
    i2E